231 related articles for article (PubMed ID: 15180339)
1. Involvement of P-glycoprotein in the transport of saquinavir and indinavir in rat brain microvessel endothelial and microglia cell lines.
Ronaldson PT; Lee G; Dallas S; Bendayan R
Pharm Res; 2004 May; 21(5):811-8. PubMed ID: 15180339
[TBL] [Abstract][Full Text] [Related]
2. Modulation of P-glycoprotein function in human lymphocytes and Caco-2 cell monolayers by HIV-1 protease inhibitors.
Profit L; Eagling VA; Back DJ
AIDS; 1999 Sep; 13(13):1623-7. PubMed ID: 10509562
[TBL] [Abstract][Full Text] [Related]
3. Functional expression of P-glycoprotein in rat brain microglia.
Lee G; Schlichter L; Bendayan M; Bendayan R
J Pharmacol Exp Ther; 2001 Oct; 299(1):204-12. PubMed ID: 11561081
[TBL] [Abstract][Full Text] [Related]
4. Assessment of active transport of HIV protease inhibitors in various cell lines and the in vitro blood--brain barrier.
van der Sandt IC; Vos CM; Nabulsi L; Blom-Roosemalen MC; Voorwinden HH; de Boer AG; Breimer DD
AIDS; 2001 Mar; 15(4):483-91. PubMed ID: 11242145
[TBL] [Abstract][Full Text] [Related]
5. A co-culture-based model of human blood-brain barrier: application to active transport of indinavir and in vivo-in vitro correlation.
Megard I; Garrigues A; Orlowski S; Jorajuria S; Clayette P; Ezan E; Mabondzo A
Brain Res; 2002 Feb; 927(2):153-67. PubMed ID: 11821009
[TBL] [Abstract][Full Text] [Related]
6. Multidrug resistance protein 2 (MRP2) transports HIV protease inhibitors, and transport can be enhanced by other drugs.
Huisman MT; Smit JW; Crommentuyn KM; Zelcer N; Wiltshire HR; Beijnen JH; Schinkel AH
AIDS; 2002 Nov; 16(17):2295-301. PubMed ID: 12441801
[TBL] [Abstract][Full Text] [Related]
7. Interaction of anti-HIV protease inhibitors with the multidrug transporter P-glycoprotein (P-gp) in human cultured cells.
Washington CB; Duran GE; Man MC; Sikic BI; Blaschke TF
J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Nov; 19(3):203-9. PubMed ID: 9803961
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of placental P-glycoprotein: impact on indinavir transfer to the foetus.
Sudhakaran S; Rayner CR; Li J; Kong DC; Gude NM; Nation RL
Br J Clin Pharmacol; 2008 May; 65(5):667-73. PubMed ID: 18093255
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of the CYP3A4-mediated metabolism and P-glycoprotein-mediated transport of the HIV-1 protease inhibitor saquinavir by grapefruit juice components.
Eagling VA; Profit L; Back DJ
Br J Clin Pharmacol; 1999 Oct; 48(4):543-52. PubMed ID: 10583025
[TBL] [Abstract][Full Text] [Related]
10. HIV protease inhibitor ritonavir: a more potent inhibitor of P-glycoprotein than the cyclosporine analog SDZ PSC 833.
Drewe J; Gutmann H; Fricker G; Török M; Beglinger C; Huwyler J
Biochem Pharmacol; 1999 May; 57(10):1147-52. PubMed ID: 11230802
[TBL] [Abstract][Full Text] [Related]
11. Functional expression and localization of P-glycoprotein at the blood brain barrier.
Bendayan R; Lee G; Bendayan M
Microsc Res Tech; 2002 Jun; 57(5):365-80. PubMed ID: 12112443
[TBL] [Abstract][Full Text] [Related]
12. Quantitative assessment of HIV-1 protease inhibitor interactions with drug efflux transporters in the blood-brain barrier.
Bachmeier CJ; Spitzenberger TJ; Elmquist WF; Miller DW
Pharm Res; 2005 Aug; 22(8):1259-68. PubMed ID: 16078135
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic interactions between HIV-1 protease inhibitors in rats: study on combinations of two kinds of HIV-1 protease inhibitors.
Shibata N; Matsumura Y; Okamoto H; Kawaguchi Y; Ohtani A; Yoshikawa Y; Takada K
J Pharm Pharmacol; 2000 Oct; 52(10):1239-46. PubMed ID: 11092568
[TBL] [Abstract][Full Text] [Related]
14. Saquinavir induces stable and functional expression of the multidrug transporter P-glycoprotein in human CD4 T-lymphoblastoid CEMrev cells.
Dupuis ML; Flego M; Molinari A; Cianfriglia M
HIV Med; 2003 Oct; 4(4):338-45. PubMed ID: 14525546
[TBL] [Abstract][Full Text] [Related]
15. P-Glycoprotein and transporter MRP1 reduce HIV protease inhibitor uptake in CD4 cells: potential for accelerated viral drug resistance?
Jones K; Bray PG; Khoo SH; Davey RA; Meaden ER; Ward SA; Back DJ
AIDS; 2001 Jul; 15(11):1353-8. PubMed ID: 11504956
[TBL] [Abstract][Full Text] [Related]
16. Transepithelial transport of prodrugs of the HIV protease inhibitors saquinavir, indinavir, and nelfinavir across Caco-2 cell monolayers.
Rouquayrol M; Gaucher B; Roche D; Greiner J; Vierling P
Pharm Res; 2002 Nov; 19(11):1704-12. PubMed ID: 12458677
[TBL] [Abstract][Full Text] [Related]
17. Intracellular concentration of the HIV protease inhibitors indinavir and saquinavir in human endothelial cells.
Armbruster C; Vorbach H; Steindl F; El Menyawi I
J Antimicrob Chemother; 2001 Apr; 47(4):487-90. PubMed ID: 11266428
[TBL] [Abstract][Full Text] [Related]
18. Multidrug resistance protein 1-mediated transport of saquinavir by microglia.
Dallas S; Ronaldson PT; Bendayan M; Bendayan R
Neuroreport; 2004 May; 15(7):1183-6. PubMed ID: 15129170
[TBL] [Abstract][Full Text] [Related]
19. Microglial activation decreases retention of the protease inhibitor saquinavir: implications for HIV treatment.
Dallas S; Block ML; Thompson DM; Bonini MG; Ronaldson PT; Bendayan R; Miller DS
J Neuroinflammation; 2013 May; 10():58. PubMed ID: 23642074
[TBL] [Abstract][Full Text] [Related]
20. In-vitro and in-vivo pharmacokinetic interactions of amprenavir, an HIV protease inhibitor, with other current HIV protease inhibitors in rats.
Shibata N; Gao W; Okamoto H; Kishida T; Yoshikawa Y; Takada K
J Pharm Pharmacol; 2002 Feb; 54(2):221-9. PubMed ID: 11848286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
